Literature DB >> 8352780

Ovariectomy decreases the mRNA levels of transforming growth factor-beta 1 and increases the mRNA levels of osteocalcin in rat bone in vivo.

T Ikeda1, C Shigeno, R Kasai, H Kohno, S Ohta, H Okumura, J Konishi, T Yamamuro.   

Abstract

Estrogen depletion causes postmenopausal osteoporosis. Here we report that steady state mRNA levels of transforming growth factor-beta 1 (TGF-beta 1) and osteocalcin in bone persistently decreased and increased, respectively, in vivo in estrogen-depleted rats after ovariectomy (OVX). 21 female Wistar rats (7-month-old) were randomized and underwent OVX or sham-operation, total RNA was extracted from tibiae and assessed by Northern blot analysis. OVX induced 70-80% decrease in TGF-beta 1 mRNA levels and 2- to 3-fold increase in mRNA levels of osteocalcin compared with controls three weeks after surgery. These changes persisted up to twelve weeks post-operation. OVX caused 15% reduction in femoral bone mineral density and 2-fold elevation in serum osteocalcin levels as early as two weeks post-operation. Moreover, estrogen depletion resulted in marked decrease and increase, respectively, in steady state mRNA levels of TGF-beta 1 and osteocalcin in vitro in osteoblastic rat osteosarcoma cells, ROS 17/2.8. Our results provide the first in vivo evidence that expression of TGF-beta and osteocalcin in bone is reciprocally regulated at the transcriptional level in estrogen deficient OVX rats and suggests that TGF-beta 1 may play a role in estrogen-dependent maintenance of normal bone density.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8352780     DOI: 10.1006/bbrc.1993.1954

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Local bone turnover in the metaphysis of the proximal tibia and the lumbar vertebra during the early periods after ovariectomy in rats.

Authors:  M Yamaura; T Nakamura; H Tsurukami; A Hijioka; K Narusawa; H Ohnishi; T Ohta; K Hosoda
Journal:  Calcif Tissue Int       Date:  1996-01       Impact factor: 4.333

2.  The effect of Astragalus extractive on alveolar bone rebuilding progress of tooth extracted socket of ovariectomied rats.

Authors:  Xiaochen Liu; Runju Zhang; Yi Zhou; Yanli Yang; Hongling Si; Xiaohong Li; Li Liu
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-08-23

3.  Beneficial regulation of type I collagen and matrixmetalloproteinase-1 expression by estrogen, progesterone, and its combination in skin fibroblasts.

Authors:  Neena Philips; Jan Devaney
Journal:  J Am Aging Assoc       Date:  2003-07

4.  Transforming growth factor-beta1 modulates chondrocyte responsiveness to 17beta-estradiol.

Authors:  E Nasatzky; D Grinfeld; B D Boyan; D D Dean; A Ornoy; Z Schwartz
Journal:  Endocrine       Date:  1999-12       Impact factor: 3.633

Review 5.  Perspective on post-menopausal osteoporosis: establishing an interdisciplinary understanding of the sequence of events from the molecular level to whole bone fractures.

Authors:  L M McNamara
Journal:  J R Soc Interface       Date:  2009-10-21       Impact factor: 4.118

6.  Expression of TGF-β1 in the blood during fracture repair in an estrogen-deficient rat model.

Authors:  Mohamed Abdalla Estai; Farihah Suhaimi; Srijit Das; Ahmad Nazrun Shuid; Zahiah Mohamed; Ima-Nirwana Soelaiman
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

7.  Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts.

Authors:  T Kameda; H Mano; T Yuasa; Y Mori; K Miyazawa; M Shiokawa; Y Nakamaru; E Hiroi; K Hiura; A Kameda; N N Yang; Y Hakeda; M Kumegawa
Journal:  J Exp Med       Date:  1997-08-18       Impact factor: 14.307

8.  Olive oil and vitamin D synergistically prevent bone loss in mice.

Authors:  Camille Tagliaferri; Marie-Jeanne Davicco; Patrice Lebecque; Stéphane Georgé; Marie-Jo Amiot; Sylvie Mercier; Amélie Dhaussy; Alain Huertas; Stéphane Walrand; Yohann Wittrant; Véronique Coxam
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.